August 13, 2014
NPR’s Morning Edition interviews Arturo Casadevall, M.D., Ph.D., on the controversy surrounding research on dangerous lab-made pathogens. Following the mishandling of smallpox by the CDC, the potential exposure of CDC scientists to live anthrax and even the recent the spread of Ebola, biologists and others are calling on the National Academy of Sciences to provide guidance on when and under what conditions research using lab-manipulated pathogens should be allowed to move forward. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein. (Dr. Casadevall’s interview begins at 4:38 in the audio version)
Dr. Casadevall's ProfileMore coverage on Dr. Casadevall
August 6, 2014
NBC News interviews Arturo Casadevall, M.D., Ph.D., about the history of using serums and antibodies to combat disease in light of an experimental Ebola treatment. Dr. Casadevall notes that antibody treatments, which are most known for fighting infectious diseases, have also had an enormous impact on treating certain cancers, such as breast and colon cancer. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.
More CoverageDr. Casadevall's ProfileMore coverage on Dr. Casadevall
August 5, 2014
CBSNews.com interviews Kartik Chandran, Ph.D., about the Ebola outbreak and his research on the virus. Dr. Chandran explains how Ebola enters cells and that his and other scientists’ research has identified new targets for drug development. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
More CoverageDr. Chandran's ProfileMore coverage on Dr. Chandran
August 5, 2014
The Washington Post reports on research by Joe Verghese, M.B.B.S., that predicts pre-dementia by measuring walking speed and cognitive abilities. The quick, low-tech test determined that 1 in 10 older adults have pre-dementia. The study involved 27,000 people in 7 countries. It found that those who had unusually slow walking speed and cognitive complaints are twice as likely to develop dementia within 12 years. Dr. Verghese is professor of neurology at Einstein and chief of the division of geriatrics at Einstein and Montefiore Medical Center.
More CoverageDr. Verghese's ProfileMore coverage on Dr. Verghese
August 1, 2014
ABC-TV’s “Good Morning America” interviews Keith Ayoob, Ed.D., about a new CDC report that found nearly 25 percent of parents underestimate their children’s weight. The study also found that 27 percent of children and teens underestimate their own weight. Dr. Ayoob notes parents often believe that their children will outgrow being overweight, which is unlikely, and cautions against waiting to make dietary and lifestyle changes. Dr. Ayoob is associate clinical professor of pediatrics and director of the nutrition clinic at the Children's Evaluation and Rehabilitation Center at Einstein.
Dr. Ayoob's ProfileMore coverage on Dr. Ayoob
July 16, 2014
The New York Times interviews Richard Lipton, M.D., about research from the Einstein Aging Study (EAS) which found an association between perceived stress and dementia. As part of two separate EAS studies, participants were surveyed about perceived stress. For healthy participants, cognitive loss was associated with scoring highest for stress and anxiety over a four-year period while the risk of dementia was two-and-a-half times greater for participants who had amnestic mild cognitive impairment and the highest perceived stress. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
July 10, 2014
Huffington Post featured an op-ed co-written by Kartik Chandran, Ph.D., that addresses why no drug has been developed to cure Ebola. Dr. Chandran and co-author John Dye, Ph.D., of the United States Army Medical Research Institute of Infectious Diseases, note that industry might be hesitant to invest in research for a drug that treats a virus infecting a relatively small number of people. They also call for innovative academia-industry partnerships. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
June 30, 2014
New York Times' "Room for Debate,” on online op-ed section, included a contribution from Michael Lipton, M.D., Ph.D., on a new campaign to limit heading by youth soccer players. The discussion was sparked by a campaign launched by former Women’s U.S. National Soccer Team players who recommend heading be banned until players reach high school. The New York Times coverage on the campaign cited Dr. Lipton’s research on the impact of heading on amateur soccer players. Dr. Lipton is associate professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
June 30, 2014
The Science Channel’s “Through The Wormhole” interviews Kartik Chandran, Ph.D., about how the deadly Ebola virus infects humans. Dr. Chandran notes that viruses like Ebola have evolved to exploit access ways into cells, likening the behavior to using a lock pick to break into a padlock. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
June 24, 2014
The Washington Post interviews Solomon Moshé, M.D., about the case of a girl with a rare form of epilepsy that causes uncontrolled bouts of laughter. Dr. Moshe notes that these gelastic seizures aren’t sparked by happiness and can actually be quite scary for the patient. Dr. Moshé is director of the division of pediatric neurology and professor in The Saul R. Korey Department of Neurology and The Dominick P. Purpura Department of Neuroscience at Einstein as well as chief of pediatric neurology at The Children’s Hospital at Montefiore.
More CoverageDr. Solomon's ProfileMore coverage on Dr. Solomon
June 4, 2014
WNYC.com features a Bronx cancer survivor and her BOLD Buddy, a volunteer for an Einstein-Montefiore program directed by Dr. Alyson Moadel-Robblee that provides personal support for cancer patients. Dr. Moadel-Robblee is associate professor of clinical epidemiology & population health and of clinical medicine at Einstein and director of the psychosocial oncology program at the Albert Einstein Cancer Center.
Dr. Moadel-Robblee's ProfileMore coverage on Dr. Moadel-Robblee
June 2, 2014
New York Daily News interviews John Greally, M.B., B.Ch., Ph.D., about his study that found environmental influences may play a role in the development of autism. Dr. Greally identified epigenetic changes, which can control which genes are turned on or off, that may be implicated. Dr. Greally is professor of genetics, of medicine and of pediatrics, director of the Center for Epigenomics and the Ruth L. and David S. Gottesman Faculty Scholar for Epigenomics at Einstein and attending physician, pediatrics at The Children's Hospital at Montefiore.
More CoverageDr. Greally's ProfileMore coverage on Dr. Greally
May 19, 2014
The Boston Globe highlights research by Michael Lipton, M.D., Ph.D., on the long-term impact of repetitive heading in soccer on the brain. Dr. Lipton explains that with lower levels of heading, the brain may be able to repair itself in most players. However, there appears to be a tipping point—approximately 1,800 headers per year—where trauma results in long-term problems, such as memory loss. Dr. Lipton is associate professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore Medical Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton